INNATE PHARMA SA (IPH.PA) Stock Analyst Ratings

EPA:IPH • FR0010331421

1.408 EUR
+0 (+0.14%)
Last: Feb 23, 2026, 01:51 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to IPH.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 6.27. This target is 345.53% above the current price.
  • IPH.PA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about IPH.PA.
  • In the previous month the buy percentage consensus was at a similar level.
  • IPH.PA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
IPH.PA Historical Analyst RatingsIPH.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.416.166.276.276.51 - 337.57% 345.53% 345.53% 362.36%

Related screens

Find peers 30% below price target
IPH.PA Current Analyst RatingIPH.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades

INNATE PHARMA SA / IPH.PA FAQ

Can you provide the average price target for INNATE PHARMA SA stock?

8 analysts have analysed IPH.PA and the average price target is 6.27 EUR. This implies a price increase of 345.53% is expected in the next year compared to the current price of 1.408.


What is the consensus rating for IPH stock?

The consensus rating for INNATE PHARMA SA (IPH.PA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.